Event Type
Disclosure
Mandatory
Variant
8-K
. Entry into a Material Definitive Agreement. On December 23, 2025, Pelthos Therapeutics Inc., a Nevada corporation (the “ Company ”) entered into an Asset Purc
. Other Events. On January 5, 2026, the Company will issue a press release announcing the closing of the transactions contemplated by the Asset Purchase Agreeme
. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 10.1* Asset Purchase Agreement, dated as of December 23, 2025, by and between Pelthos